Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit
可手术头颈癌患者接受新辅助靶向治疗后,生存获益显著
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-1768
Mascarella, Marco A; Olonisakin, Tolani F; Rumde, Purva; Vendra, Varun; Nance, Melonie A; Kim, Seungwon; Kubik, Mark W; Sridharan, Shaum S; Ferris, Robert L; Fenton, Moon J; Clayburgh, Daniel R; Ohr, James P; Joyce, Sonali C; Sen, Malabika; Herman, James G; Grandis, Jennifer R; Zandberg, Dan P; Duvvuri, Umamaheswar